Aim: To develop a simple and sensitive high-performance liquid chromatography method to determine plasmatic levels of trimethoprim/sulfamethoxazole in paediatric population. Method: Chromatographic separation was carried out using a reverse phase column with detection ultraviolet at a wavelength of 225 nm. The mobile phase consists of phosphate buffer 0.1 M, acetonitrile and methanol, (65:20:15) with a flow of 1.0 ml/min. Results: Calibration curve was linear over the concentration range for trimethoprim of 0.25 to 5 µg/ml and 5 to 100 µg/ml for sulfamethoxazole. Precision were found to be within 15% for both compounds. The detection limits and quantifications for trimethoprim/sulfamethoxazole were 0.2 -0.25 µg/ml and 3 -5 µg/ml respectively. Conclusions: The developed method was applied for the quantification of both compounds in plasma samples of two patients resulting concentrations within the therapeutic ranges. The method is convenient for pharmacokinetic studies.
bution (Vd) in comparison with SMX which is even more hydrophilic and a weak acid with 6.0 pKa [1] . The combination of TMP/SMX is used in a proportion of 1:5 which produces concentrations in plasma in the proportion of 1:20, amount that gives an increase in optimum antibacterial activity. Individually, both TMP/SMX are efficient antibacterial drugs of the family of folate antagonists.
In children the dose varies from 3 mg/kg/8h to 4 mg/kg/12h [1] [2] . TMP/SMX is effective for: Staphylococcus, Streptococuus, Enterobacteriaceas, Salmonella, Shigella, Haemophilus influenza, treatment of Pneumocystis carinii in patients with HIV and many different species [1] [2] [3] [4] . The combination of these drugs continued to be one of the most used antibiotics in the clinic.
Several analytical methods for the quantification of these compounds with UV detection, mass spectrometry or by electrophoresis have been developed. Previous HPLC methods have the inconvenient that the retention time is a little more prolonged or that the extraction process is more tedious or not quantified small unities [5] [6] [7] [8] . The objective of the present study was to develop a simple, economical, precise, fast and exact method of HPLC for simultaneous determination of TMP/SMX for pharmacokinetic studies. 
Methods

Chromatographic System
Chemicals and Reagents
TMP/SMX, and Sulfamethazine USP grade were obtained from Sigma. Anhydrous sodium phosphate, perchloric acid, acetic acid, water, acetonitrile and methanol (HPLC grade) were purchased from J.T. Baker all other chemicals and solvents used were of analytical grade. Standard solutions for the compounds trimethoprim (1 mg/ml), sulfamethoxazole (2 mg/ml.) were prepared and sulfamethazine (1 mg/ml) was used as internal standard (IS). The compounds were dissolved in methanol and used to prepare the concentrations for calibration curve in plasma with a concentration range of 0.25 to 5 µg/ml for TMP and of 5 to 100 µg/ml for SMX. The internal standard was prepared at a concentration of the mixture and shaken to maximum speed in vortex for 1 min. It was then centrifuged at 4500 revolutions per minute for 10 min. The supernatant was separated and transferred to a micro-vial and from this was injected 150 µl to chromatographic system.
Assay Validation
Validation of the method shown later, was carried out according to the guidelines published in the Official Mexican Norm NOM-177-1998 [9] . The calibration curve in plasma was carried out with the following equivalent points 0.25, 0.5, 1, 2, 4, 5 µg/ml for TMP and 5, 10, 20, 40, 80, and 100 µg/ml for SMX. In With regard to inter-day variability, the same concentrations for trimethoprim and sulfamethoxazole were analysed in triplicate over three consecutive days.
Absolute recovery was determined as the percentage of drug by extracting both compounds from the plasma and the resulting solution (n = 6) compared to the drug dissolved in methanol. To evaluate selectivity of method the following compounds in plasma: acetylsalicylic acid, salicylic acid, acetaminophen, ibuprofen, paracetamol and heparin, were assayed in order to detect possible interferences of the compounds under study, and from other medication administered concomitantly. The latter was considered important since interference in quantification of the compound being analysed should be zero. Table 1 . The method is found to be selective on injecting them with other compounds (acetylsalicylic acid, salicylic acid, acetaminophen, ibuprofen, paracetamol and heparin) as shown too in Figure 1 . Both compounds were stable for at least 60 days at −4˚C and 120 days at −70˚C. To evaluate if the method was applicable, the quantification of the levels of 
Results
Discussion
In Mexico, the combination of TMP/SMX is used to treat several infective diseases in children, mainly the urinary tract. As part of a study protocol for children with UTI, was designed a reliable, easy-going, sensible and precise HPLC method for simultaneous determination of TMP and SMX and which could be applied for analysis of both drugs in pharmacokinetic and bioavailability studies.
We report herein the result of validation of such method to measure TMP/SMX and for clinical follow-up of the children subjected to this treatment. Currently, we are preparing the manuscript where results of the pharmacokinetics study are described.
The determinations of the concentrations of TMP/SMX were carried out using high resolution liquid chromatographic based on a method previously reported by Sayar et al. [5] .
The new method has an important advantage over others that have already been published methods. For example, with shorter retention times of SMX decreases of 9.0 min at 6.8 min TMP of 5.0 min at 3.5 min. Residual contaminants being washed off from the column before each injection and another advantage of this method is that there is no need to adjust pH.
Conclusion
This method for quantifying TMP/SMX is simple, reliable, fast and specific for its application in pharmacokinetic studies and therapeutic monitoring in paedi- 
